Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Genome Biology
- Vol. 9 (6), R92-13
- https://doi.org/10.1186/gb-2008-9-6-r92
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Utilizing RNA interference to enhance cancer drug discoveryNature Reviews Drug Discovery, 2007
- Discovery and development of sorafenib: a multikinase inhibitor for treating cancerNature Reviews Drug Discovery, 2006
- A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and TumorigenicityCell, 2005
- A Genetic Screen for Candidate Tumor Suppressors Identifies RESTCell, 2005
- Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistanceNature, 2005
- Small RNAs: Classification, Biogenesis, and FunctionMolecules and Cells, 2005
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras geneNature, 1982